Carnegie Capital Asset Management, LLC Astrazeneca PLC Transaction History

Carnegie Capital Asset Management, LLC

$3.38 Billion
Q4 2024

A detailed history of Carnegie Capital Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 16,492 shares of AZN stock, worth $1.21 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,492

Previous 17,338 4.88%

Holding current value

$1.21 Million

Previous $1.35 Million 20.0%

% of portfolio

0.03%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$63.2 - $79.58 $53,467 - $67,324	-846 Reduced 4.88%	16,492 $1.08 Million
Q3 2024 Oct 10, 2024	BUY	$76.67 - $87.62 $5,290 - $6,045	69 Added 0.4%	17,338 $1.35 Million
Q2 2024 Jul 19, 2024	BUY	$66.81 - $80.83 $9,219 - $11,154	138 Added 0.81%	17,269 $1.35 Million
Q1 2024 May 03, 2024	SELL	$61.03 - $69.57 $41,683 - $47,516	-683 Reduced 3.83%	17,131 $1.16 Million
Q4 2023 Jan 29, 2024	SELL	$61.89 - $69.28 $1,052 - $1,177	-17 Reduced 0.1%	17,814 $1.2 Million
Q3 2023 Oct 10, 2023	SELL	$64.85 - $71.7 $648 - $717	-10 Reduced 0.06%	17,831 $1.21 Million
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $1,398 - $1,516	-20 Reduced 0.11%	17,841 $1.28 Million
Q1 2023 Apr 19, 2023	BUY	$63.15 - $71.6 $28,543 - $32,363	452 Added 2.6%	17,861 $1.24 Million
Q4 2022 Jan 23, 2023	BUY	$54.21 - $70.44 $13,931 - $18,103	257 Added 1.5%	17,409 $0
Q3 2022 Oct 13, 2022	BUY	$53.02 - $135.75 $35,258 - $90,273	665 Added 4.03%	17,152 $941,000
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $73,897 - $88,711	-1,247 Reduced 7.03%	16,487 $1.09 Million
Q2 2022 Jul 13, 2022	BUY	$59.26 - $71.14 $59,082 - $70,926	997 Added 5.96%	17,734 $1.06 Million
Q1 2022 Apr 11, 2022	SELL	$55.72 - $67.12 $61,236 - $73,764	-1,099 Reduced 6.16%	16,737 $1.11 Million
Q4 2021 Jan 21, 2022	BUY	$54.02 - $63.83 $5,510 - $6,510	102 Added 0.58%	17,836 $1.04 Million
Q2 2021 Jul 16, 2021	BUY	$48.42 - $60.18 $858,680 - $1.07 Million	17,734 New	17,734 $1.06 Million
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $178,068 - $212,933	-3,670 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$53.07 - $61.1 $194,766 - $224,237	3,670 New	3,670 $201,000
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $220,127 - $247,778	-5,972 Closed	0 $0
Q3 2018 Nov 27, 2018	BUY	$34.76 - $39.72 $207,586 - $237,207	5,972 New	5,972 $244,000

Others Institutions Holding AZN

# of Institutions

1,351

Shares Held

489M

Call Options Held

5.88M

Put Options Held

4.1M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.

Account

Carnegie Capital Asset Management, LLC Astrazeneca PLC Transaction History